Evidence map›Paper›PMID 41824765›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Programmable RNA N

Yang Li, Xiangmin Tan, Yaran Liu, Yongquan He, Bo Yuan, Ping Wang, Guangzhi Ma, Mengzhe Guo, Jian Zhou, Qiang Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yang LiGenetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Department of Laboratory Medicine, School of Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Xiangmin TanCenter For RNA Medicine, and International School of Medicine, the Fourth Affiliated Hospital of School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Yaran LiuInstitute of Medical Artificial Intelligence, Binzhou Medical College, Yantai, China.
Yongquan HeGenetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Department of Laboratory Medicine, School of Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Bo YuanInstitute of Artificial Intelligence, Beihang University, Haidian, Beijing, China.
Ping WangCenter For RNA Medicine, and International School of Medicine, the Fourth Affiliated Hospital of School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Guangzhi MaDepartment of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.
Mengzhe GuoSchool of Pharmacy, Xuzhou Medical University, Xuzhou, China.
Jian ZhouDepartment of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.
Qiang SunCenter For RNA Medicine, and International School of Medicine, the Fourth Affiliated Hospital of School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.ORCID https://orcid.org/0000-0002-6621-7064

Funding

"Case-by-Case Introduction of Top Talent (Teams)" Program in YantaiJinhua Science and Technology Bureau 2024-3-121National Natural Science Foundation of China 32400631National Natural Science Foundation of China 82102968National Natural Science Foundation of China 82203444National Natural Science Foundation of China 82403748Zhejiang Provincial Natural Science Foundation of China LZY24H070002
6 · The paper itself

Abstract

N

Indexed as

AdenosineRNA EditingRNA, MessengerEpitranscriptomeHumansRNA MethylationAdenosineN(6),O(2)-dimethyladenosineRNA, MessengerCRISPR‐Cas13N6,2´‐O‐dimethyladenosineRNA editingRNA modification

Identifiers

PMID41824765
PMCPMC13205690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.